Your session is about to expire
← Back to Search
Electrolyte Supplement
Dietary Potassium Liberalization for Chronic Kidney Disease (DK-LIB Trial)
N/A
Recruiting
Led By Dylan Mackay, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants who have an estimated glomerular filtration rate between 15 and 45 ml/min/1.73m2
Male or female, aged 18 years or above
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between endpoints of each experimental period (week 8 to week 16)
Awards & highlights
DK-LIB Trial Summary
This trial will study the effects of different potassium levels in fruits and vegetables on people with Chronic Kidney Disease. It will measure things like blood pressure and quality of life. The results could change dietary recommendations for people with CKD.
Who is the study for?
This trial is for English-speaking adults over 18 with Chronic Kidney Disease, who are not on dialysis but have a certain level of kidney function and controlled blood sugar. They should have slightly elevated potassium levels but not be in advanced heart failure, recently had a heart attack or stroke, or have severe lung disease requiring oxygen.Check my eligibility
What is being tested?
The study tests if eating fruits and vegetables with different amounts of potassium affects blood potassium levels in CKD patients. It's a randomized crossover trial where participants will get home deliveries of these foods to include in their diet and then switch after some time.See study design
What are the potential side effects?
Since the intervention involves dietary changes rather than medication, side effects may be minimal but could include changes in blood pressure or digestive discomfort due to increased fruit and vegetable intake.
DK-LIB Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My kidney function, measured by filtration rate, is low but not extremely low.
Select...
I am 18 years old or older.
DK-LIB Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ between endpoints of each experimental period (week 8 to week 16)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between endpoints of each experimental period (week 8 to week 16)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in serum potassium concentrations between treatments
Secondary outcome measures
Change in physical function related quality of life between treatments
Change in urinary potassium between treatments
Change in urinary sodium between treatments
+8 moreDK-LIB Trial Design
2Treatment groups
Experimental Treatment
Group I: Restricted dietary potassium and then liberalized potassium via fruit and vegetablesExperimental Treatment2 Interventions
Participants will receive weekly supplementation of higher potassium fruit and vegetables via grocery home delivery during the liberalized dietary potassium 2 week run-in and then start receiving a restricted potassium treatment period, then cross-over to the liberalized potassium treatment period following a 2-week washout period. Participants will receive a 30-60 minute dietary counseling session in the first week of each treatment period from a registered dietitian (RD), either in person or via videoconference, depending on regional COVID-19 restrictions and participant preference, which will outline the concepts of the dietary intervention. The RD will also recommend the best ways to prepare and include the fruit and vegetables into the participant's current diet
Group II: Liberalized dietary potassium and then restricted potassium via fruit and vegetablesExperimental Treatment2 Interventions
Participants will receive weekly supplementation of higher potassium fruit and vegetables via grocery home delivery during the liberalized dietary potassium 2-week run-in and liberalized potassium treatment period, then cross-over to the restricted potassium treatment period following a 2-week washout period. Participants will receive a 30-60 minute dietary counseling session in the first week of each treatment period from a registered dietitian (RD), either in person or via videoconference, depending on regional Coronavirus disease (COVID)-19 restrictions and participant preference, which will outline the concepts of the dietary intervention. The RD will also recommend the best ways to prepare and include the fruit and vegetables into the participant's current diet.
Find a Location
Who is running the clinical trial?
University of ManitobaLead Sponsor
593 Previous Clinical Trials
199,358 Total Patients Enrolled
Dalhousie UniversityOTHER
166 Previous Clinical Trials
403,083 Total Patients Enrolled
Dylan Mackay, PhDPrincipal InvestigatorUniversity of Manitoba
5 Previous Clinical Trials
227 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your blood potassium level is between 4.9 and 5.5 mEq/L.My kidney function, measured by filtration rate, is low but not extremely low.I haven't had serious kidney issues or very high potassium levels in the last 6 months.I have not had a heart attack or stroke in the last 6 months.I have COPD and need oxygen therapy.I am currently pregnant or breastfeeding.Your hemoglobin A1c level is less than 11%.I cannot swallow pills or have stomach issues that prevent me from taking certain medications.I have severe heart failure symptoms or have had a heart, liver, or kidney transplant.I am currently taking medication to control my potassium levels.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Liberalized dietary potassium and then restricted potassium via fruit and vegetables
- Group 2: Restricted dietary potassium and then liberalized potassium via fruit and vegetables
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor still enrolling participants?
"Clinicaltrials.gov indicates that this clinical trial is not currently accepting participants as it was first published on December 1st 2022 and last updated October 31st 2022. Nevertheless, there are 513 other trials recruiting right now for those interested in taking part in medical research."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger